Day: July 18, 2022

18 July 2022 Admiral Group appoints Keith Davies as Group Chief Risk and Compliance Officer Admiral Group Plc (“Admiral”) announces the appointment of Keith Davies as Group Chief Risk and Compliance Officer with effect from September 2022. Keith will be responsible for developing, implementing and overseeing Admiral’s Risk and Compliance functions and frameworks in ways that support the safe delivery of Admiral’s strategic objectives. Keith will report into Milena Mondini de Focatiis, Admiral’s Group CEO. Keith has extensive experience in risk management and compliance and joins from Federated Hermes Limited where he was Chief Risk & Compliance Officer. Before joining Federated Hermes in 2020, Keith was the Chief Risk and Resilience Officer for M&G Plc (“M&G”) where he was a member of the Executive Committee that prepared...

BEIJING, July 18, 2022 (GLOBE NEWSWIRE) — So-Young International Inc. (Nasdaq: SY) (“So-Young” or the “Company”), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it has received a written notification from the staff of the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) dated July 15, 2022, indicating that for the last 30 consecutive business days, the closing bid price of the Company’s American depositary shares (the “ADSs”) was below the minimum bid price of US$1.00 per share requirement set forth in Nasdaq Listing Rule 5450(a)(1). The Nasdaq notification letter has no current effect on the listing or trading of the Company’s ADSs on Nasdaq. Pursuant to the Nasdaq Listing Rule 5810(c)(3)(A),...

A number of contracts of varying size have been signed Deliveries to start immediately aiming to ensure a rapid response to the current monkeypox outbreak Company upgrades its financial guidance for 2022COPENHAGEN, Denmark, July 18, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today the signing of a number of supply contracts with undisclosed countries for the Company’s smallpox vaccine with the aim to ensure sufficient supply to meet the requirements for vaccinating individuals at risk for monkeypox in the short to medium term. The vaccine is approved for use against monkeypox by the U.S. Food and Drug Administration and Health Canada as the only vaccine having obtained regulatory approval for this indication in any territory. Bavarian Nordic will continue the dialogue with countries concerning supply of the vaccine to mitigate...

Icelandair will publish its financial results for the second quarter of 2022 on Thursday 21 July 2022. An investor presentation will be webcasted in English in relation to the disclosure of the results at 8:30 am on 22 July 2022 at: http://icelandairgroup.is   The presentation will be available after the meeting on the Company’s website.

  Paris, July 18, 2022,     Disclosure of Transactions in Own Shares   In accordance with the authorization given by the shareholders’ annual meeting on July 6, 2021 to trade on its own shares and pursuant to applicable law on share repurchase, Kering (LEI: 549300VGEJKB7SVUZR78) declares the following purchases of its own shares (FR0000121485) from July 11 to 15, 2022:  Issuer’s name Issuer’s identifying code Date of transaction Identifying code of financial instrument Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares Market (MIC code)KERING 549300VGEJKB7SVUZR78 11/07/2022 FR0000121485 181 486.6110 XPARKERING 549300VGEJKB7SVUZR78 12/07/2022 FR0000121485 1,351 489.5937 XPARKERING 549300VGEJKB7SVUZR78 13/07/2022 FR0000121485...

Hydro’s second quarter results 2022 will be released at 07:00 CEST (01:00 EST, 06:00 UTC/GMT), on Friday, July 22, 2022. The quarterly report and presentation slides will be available on www.hydro.com at the same time.  Executive Vice President and Chief Financial Officer Pål Kildemo will host an audio webcast and a conference call, in English, at 08:30 CEST the same day. There will be no physical presentation or press conference.  To listen to the presentation, please join the audio webcast. There will be a Q&A session directly after the presentation. If you would like to ask questions, you need to join the conference call before the end of the presentation. To join the conference call and ask questions, register your details using this registration link. Once registered, you will receive a separate email containing your dial-in...